Cargando…
SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway
Esophageal cancer (EC) is known as a type of common malignant tumor, with the incidence ranking eighth worldwide. Because of the high metastasis of advanced EC, the total survival rate has been quite low. Esophageal squamous cell carcinoma (ESCC) is a main type of EC. Targeted therapy for ESCC has b...
Autores principales: | Ren, Chunhong, Zhou, Zhengbo, Wang, Xiuzhen, Hua, Xu, Zou, Muping, Zhang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993916/ https://www.ncbi.nlm.nih.gov/pubmed/32769441 http://dx.doi.org/10.1097/PAI.0000000000000858 |
Ejemplares similares
-
SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis
por: Peng, Changliang, et al.
Publicado: (2017) -
EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression
por: Liu, Lei, et al.
Publicado: (2018) -
MicroRNA-181a promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma via the TGF-β/Smad pathway
por: Xu, Run, et al.
Publicado: (2021) -
SHCBP1 Promotes the Proliferation of Breast Cancer Cells by Inhibiting CXCL2
por: Yu, Xiaoke, et al.
Publicado: (2023) -
EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation
por: Yin, Hubin, et al.
Publicado: (2022)